Holen Sie sich die Stockscreener-App
315.38
0.49%
1.53
Vorhandelsmarkt:
315.65
0.27
+0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen Inc. (NASDAQ:AMGN) Announces Quarterly Dividend of $2.52 - MarketBeat
Amgen describes new GTPase KRAS mutant inhibitors - BioWorld MedTech
Amgen: Improving Balance Sheet Is Bringing The Stock Close To Being A "Buy" (NASDAQ:AMGN) - Seeking Alpha
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Intact Investment Management Inc. Sells 10,800 Shares of Amgen Inc. $AMGN - MarketBeat
Ossiam Sells 13,818 Shares of Amgen Inc. $AMGN - MarketBeat
Wells Fargo Adjusts Price Target on Amgen to $325 From $300, Maintains Equalweight Rating - marketscreener.com
Amgen (AMGN) to Participate in Upcoming Virtual Meeting - GuruFocus
Amgen Announces Dividend for the First Quarter of 2026, Payable on March 6, 2026 - marketscreener.com
Amgen Raises Quarterly Dividend to $2.52 a Share From $2.38, Payable March 6 to Shareholders of Record as of Feb. 13 - marketscreener.com
Amgen declares $2.52 per share dividend for first quarter 2026 By Investing.com - Investing.com UK
Amgen (NASDAQ: AMGN) declares $2.52 Q1 2026 dividend, record Feb. 13, pays Mar. 6 - Stock Titan
Key facts: Amgen invests $900M in Ohio; hosts Clinical Research Forum in UAE - TradingView
State Street Corp Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by SVB Wealth LLC - MarketBeat
Who Owns Amgen? Top Shareholders and Recent Insider Trades - TIKR.com
Fayez Sarofim & Co Acquires 18,213 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Daiwa Securities Group Inc. - MarketBeat
Bank of Nova Scotia Has $29.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Axa S.A. Purchases 103,665 Shares of Amgen Inc. $AMGN - MarketBeat
Rep. David Taylor Sells Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat
Amgen Inc. $AMGN Shares Bought by L2 Asset Management LLC - MarketBeat
Gabelli Funds LLC Sells 3,150 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Boosted by Federated Hermes Inc. - MarketBeat
Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 68% Above Its Share Price - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Cerity Partners LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by California Public Employees Retirement System - MarketBeat
Amgen (NASDAQ:AMGN) Cut to "Buy" at Wall Street Zen - MarketBeat
Has the Market Fully Priced In Amgen’s Rally After Pipeline and Regulatory Milestones? - simplywall.st
BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens - Finviz
Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - GlobeNewswire Inc.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - sharewise.com
A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st
Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug - Investing.com
Amgen (NASDAQ:AMGN) Rating Increased to Buy at Erste Group Bank - MarketBeat
Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen
Tema Etfs LLC Has $3.62 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
What makes Amgen Inc. (AMG0) stock appealing to growth investorsMarket Performance Recap & Smart Money Movement Alerts - Newser
Is Amgen Inc. (AMG0) stock overpriced at current multiplesEarnings Risk Report & Long-Term Investment Growth Plans - Newser
First Trust Advisors LP Sells 21,347 Shares of Amgen Inc. $AMGN - MarketBeat
Beutel Goodman & Co Ltd. Raises Position in Amgen Inc. $AMGN - MarketBeat
Baird Financial Group Inc. Cuts Position in Amgen Inc. $AMGN - MarketBeat
Arrowstreet Capital Limited Partnership Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Why Is Amgen (AMGN) Up 8% Since Last Earnings Report? - Yahoo Finance
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and MoreResearchAndMarkets.com - Business Wire
Amgen (NASDAQ:AMGN) Shareholders Have Earned a 12% CAGR Over the Last Five Years - 富途牛牛
Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN) - Seeking Alpha
Does Amgen Stock Lead the Pack? - Trefis
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 - The Motley Fool
EverSource Wealth Advisors LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Guggenheim Capital LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Will Strong Q3 Beat And Pipeline Updates Change Amgen's (AMGN) Future Earnings Narrative? - simplywall.st
BMO Capital Maintains Amgen (AMGN) Outperform Recommendation - Nasdaq
Amgen (NASDAQ:AMGN) Reaches New 12-Month HighStill a Buy? - MarketBeat
Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza - Benzinga
Key facts: Amgen reports strong growth; BMO raises price target to $372 - TradingView
Amgen stock hits 52-week high at $345.95 By Investing.com - Investing.com Nigeria
Amgen stock hits 52-week high at $345.95 - Investing.com
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally - ts2.tech
Biocon and Amgen Reach Deal to Commercialise Biosimilars in Europe - Chemical Industry Digest
BMO Capital Raises Price Target for Amgen (AMGN) to $372, Mainta - GuruFocus
BMO Capital Adjusts Price Target on Amgen to $372 From $335, Maintains Outperform Rating - marketscreener.com
Invesco Ltd. Buys 339,755 Shares of Amgen Inc. $AMGN - MarketBeat
UPC Court Of Appeal Overturns Revocation Of Amgen's PCSK9 Antibody Patent And Clarifies The UPC's Inventive Step Approach (Amgen v Sanofi And Regeneron) - MarketScreener
Goldman Sachs Maintains Price Target on Amgen (AMGN) Before Key Trial Readouts - Insider Monkey
Extensive-Stage Small Cell Lung Cancer Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | EpicentRx, Ipsen, Bristol-Myers Squibb, Xcovery Holding Company, Amgen - Barchart.com
M&T Bank Corp Sells 61,385 Shares of Amgen Inc. $AMGN - MarketBeat
Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen
OMERS ADMINISTRATION Corp Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
A Look at Amgen (AMGN) Valuation After Full FDA Approval and NCCN Guideline Update for IMDELLTRA - Yahoo Finance
Biocon Biologics settles with Amgen to launch Denosumab Biosimilars in Europe, rest of the world - Zee Business
Biocon Biologics settles with Amgen Inc to commercialise biosimilars in Europe - Daily Excelsior
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):